Meningococcal Vaccines Industry Value is Estimated to Hit USD 9.37 billion by 2026

The global meningococcal vaccines market value is estimated to hit USD 9.37 billion by 2026 and expected to grow at a CAGR of 12.3% over period 2019 to 2026.

The report analyzes and forecasts the Meningococcal Vaccines market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

DOWNLOAD FREE SAMPLE
https://www.acumenresearchandconsulting.com/request-sample/1397

The report comprises a detailed value chain analysis, which provides a comprehensive view of the global Meningococcal Vaccines market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.

Market Participants

Major companies contributing the global meningococcal vaccines market are Baxter International, Biomed Pvt. Ltd., GlaxoSmithKline plc, JN-International Medical Corporation, Novartis International, Nuron Biotech, Pfizer Inc., Sanofi SA, and Serum Institute of India Ltd.

Market Segmentation

Market Segmentation By Type:

  • Combination Vaccines
    • MenHibrix
    • Menitorix
  • Conjugate Vaccines
    • Menactra
    • MenAfriVac
    • Meningitec
    • Menjugate
    • Menveo
    • NeisVac-C
    • Nimenrix
    • NmVac4-DT
  • Polysaccharide
    • Mencevax
    • Menomune
    • NmVac4
    • Others
  • Men B Vaccines
    • Bexsero
    • Trumenba
  • Others

Market Segmentation By End User:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Others

Market Segmentation by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Table Of Content

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Meningococcal Vaccines
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Meningococcal Vaccines Market By Type
1.2.2.1. Global Meningococcal Vaccines Market Revenue and Growth Rate Comparison By Type (2015-2026)
1.2.2.2. Global Meningococcal Vaccines Market Revenue Share By Type in 2017
1.2.2.3. Combination Vaccines
1.2.2.3.1. MenHibrix
1.2.2.3.2. Menitorix
1.2.2.4. Conjugate Vaccines
1.2.2.4.1. Menactra
1.2.2.4.2. MenAfriVac
1.2.2.4.3. Meningitec
1.2.2.4.4. Menjugate
1.2.2.4.5. Menveo
1.2.2.4.6. NeisVac-C
1.2.2.4.7. Nimenrix
1.2.2.4.8. NmVac4-DT
1.2.2.5. Polysaccharide
1.2.2.5.1. Mencevax
1.2.2.5.2. Menomune
1.2.2.5.3. NmVac4
1.2.2.5.4. Others
1.2.2.6. Men B Vaccines
1.2.2.6.1. Bexsero
1.2.2.6.2. Trumenba
1.2.2.6.3. Others
1.2.3. Meningococcal Vaccines Market By End User
1.2.3.1. Global Meningococcal Vaccines Market Revenue and Growth Rate Comparison By End User (2015-2026)
1.2.3.2. Global Meningococcal Vaccines Market Revenue Share By End User in 2017
1.2.3.3. Retail Pharmacies
1.2.3.4. Hospital Pharmacies
1.2.3.5. Others
1.2.4. Meningococcal Vaccines Market by Geography
1.2.4.1. Global Meningococcal Vaccines Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Meningococcal Vaccines Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Meningococcal Vaccines Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Meningococcal Vaccines Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Meningococcal Vaccines Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Meningococcal Vaccines Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Meningococcal Vaccines Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Meningococcal Vaccines Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Meningococcal Vaccines Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Meningococcal Vaccines Major Manufacturers in 2017

CHAPTER 4. MENINGOCOCCAL VACCINES MARKET BY FORM

4.1. Global Meningococcal Vaccines Revenue By Type
4.2. Combination Vaccines
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. Conjugate Vaccines
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.4. Polysaccharide
4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.5. Men B Vaccines
4.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 5. MENINGOCOCCAL VACCINES MARKET BY END USER

5.1. Global Meningococcal Vaccines Revenue By End User
5.2. Retail Pharmacies
5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.3. Hospital Pharmacies
5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 6. NORTH AMERICA MENINGOCOCCAL VACCINES MARKET BY COUNTRY

6.1. North America Meningococcal Vaccines Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2. North America Meningococcal Vaccines Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Meningococcal Vaccines Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
6.4.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
6.5.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)

CHAPTER 7. EUROPE MENINGOCOCCAL VACCINES MARKET BY COUNTRY

7.1. Europe Meningococcal Vaccines Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2. Europe Meningococcal Vaccines Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
7.5.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
7.6.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
7.7.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET BY COUNTRY

8.1. Asia-Pacific Meningococcal Vaccines Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. Asia-Pacific Meningococcal Vaccines Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.5.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.6.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.7.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.8.2. Market Revenue and Forecast By End User, 2015 – 2026 ($Million)
…

Would like to place an order or any question, please feel free to contact at  sales@acumenresearchandconsulting.com | +1 407 915 4157

The report provides size (in terms of volume and value) of Meningococcal Vaccines market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding. Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact-based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Leave a comment

Design a site like this with WordPress.com
Get started